ZS Associates

Market Access

A panel on direct-to-patient at Reuters Pharma USA

In DTC's watershed moment, trust and partnership are key

More and more pharma companies are turning to direct-to-patient access models. But the consensus at Reuters Pharma USA is that they can't do it alone.

Digital

Simulated clinical trial populations and AI scalability

AI might still be in the modish buzzword stage, but discussions exploring the potential for its scaling within life sciences are critical.

Digital

Recursion, Exscientia, and AI drug discovery’s moment of tru...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger.

Patients

Cell and gene therapies and the tricky question of patient s...

Cell and gene therapies represent the cutting edge of pharma technology, but how are patients experiencing this treatment revolution?

Market Access

The 2024 biopharma M&A landscape: An overview

It’s been a couple of months since pharma’s annual JP Morgan Chase Healthcare Conference, where the mood around pharma M&A this year was optimistic, albeit with a few caveats.

R&D

Pharmaceutical research in space

When US President Joe Biden talks about his Cancer Moonshot, he's not literally talking about the moon - he's referencing the legendary innovation push that got Americans to the moon in 196